EYPT
Price
$10.04
Change
+$0.19 (+1.93%)
Updated
Jul 31, 02:00 PM (EDT)
Capitalization
677.11M
6 days until earnings call
RXRX
Price
$5.95
Change
-$0.00 (-0.00%)
Updated
Jul 31, 04:59 PM (EDT)
Capitalization
2.52B
5 days until earnings call
Interact to see
Advertisement

EYPT vs RXRX

Header iconEYPT vs RXRX Comparison
Open Charts EYPT vs RXRXBanner chart's image
EyePoint Pharmaceuticals
Price$10.04
Change+$0.19 (+1.93%)
Volume$100
Capitalization677.11M
Recursion Pharmaceuticals
Price$5.95
Change-$0.00 (-0.00%)
Volume$865.52K
Capitalization2.52B
EYPT vs RXRX Comparison Chart in %
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. RXRX commentary
Jul 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Buy and RXRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 31, 2025
Stock price -- (EYPT: $9.84 vs. RXRX: $5.81)
Brand notoriety: EYPT and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 61% vs. RXRX: 64%
Market capitalization -- EYPT: $677.11M vs. RXRX: $2.52B
EYPT [@Biotechnology] is valued at $677.11M. RXRX’s [@Biotechnology] market capitalization is $2.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $239.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, EYPT is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • EYPT’s TA Score: 4 bullish, 5 bearish.
  • RXRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both EYPT and RXRX are a bad buy in the short-term.

Price Growth

EYPT (@Biotechnology) experienced а -8.04% price change this week, while RXRX (@Biotechnology) price change was -9.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.50%. For the same industry, the average monthly price growth was +19.66%, and the average quarterly price growth was +45.57%.

Reported Earning Dates

EYPT is expected to report earnings on Oct 29, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.50% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.52B) has a higher market cap than EYPT($677M). EYPT YTD gains are higher at: 32.081 vs. RXRX (-14.053). EYPT has higher annual earnings (EBITDA): -144.55M vs. RXRX (-524.77M). RXRX has more cash in the bank: 500M vs. EYPT (318M). EYPT has less debt than RXRX: EYPT (24.1M) vs RXRX (92.9M). RXRX has higher revenues than EYPT: RXRX (59.8M) vs EYPT (56M).
EYPTRXRXEYPT / RXRX
Capitalization677M2.52B27%
EBITDA-144.55M-524.77M28%
Gain YTD32.081-14.053-228%
P/E RatioN/AN/A-
Revenue56M59.8M94%
Total Cash318M500M64%
Total Debt24.1M92.9M26%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EYPTRXRX
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 14 days ago
86%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BASVX13.94N/A
N/A
Brown Advisory Sustainable Val Inst
RCEYX60.09N/A
N/A
Victory RS Large Cap Alpha Y
BMCRX26.69N/A
N/A
BlackRock Advantage Large Cap Gr R
MAEIX72.25N/A
N/A
MoA Equity Index Fund
FSZZX10.46N/A
N/A
Fidelity Advisor Sustainable EM Eq Z

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-0.10%
OCUL - EYPT
59%
Loosely correlated
-0.77%
LYRA - EYPT
58%
Loosely correlated
-10.64%
RXRX - EYPT
54%
Loosely correlated
-2.35%
ATHE - EYPT
54%
Loosely correlated
-3.18%
BEAM - EYPT
53%
Loosely correlated
+1.10%
More